BR112014031248A2 - uso de micobactérias inativadas para a preparação de um medicamento para a prevenção da tuberculose. - Google Patents
uso de micobactérias inativadas para a preparação de um medicamento para a prevenção da tuberculose.Info
- Publication number
- BR112014031248A2 BR112014031248A2 BR112014031248A BR112014031248A BR112014031248A2 BR 112014031248 A2 BR112014031248 A2 BR 112014031248A2 BR 112014031248 A BR112014031248 A BR 112014031248A BR 112014031248 A BR112014031248 A BR 112014031248A BR 112014031248 A2 BR112014031248 A2 BR 112014031248A2
- Authority
- BR
- Brazil
- Prior art keywords
- tuberculosis
- drug
- prevention
- preparation
- inactivated mycobacteria
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 201000008827 tuberculosis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201200640A ES2438690B1 (es) | 2012-06-15 | 2012-06-15 | Micobacterias inactivadas para su uso por vía oral en la prevención de la tuberculosis |
PCT/ES2013/000145 WO2013186409A1 (es) | 2012-06-15 | 2013-06-13 | Micobacterias in activadas para su uso por vía oral en la prevención de la tuberculosis |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014031248A2 true BR112014031248A2 (pt) | 2017-06-27 |
Family
ID=49757626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014031248A BR112014031248A2 (pt) | 2012-06-15 | 2013-06-13 | uso de micobactérias inativadas para a preparação de um medicamento para a prevenção da tuberculose. |
Country Status (16)
Country | Link |
---|---|
US (1) | US9579371B2 (pt) |
EP (1) | EP2865388B1 (pt) |
JP (1) | JP6159396B2 (pt) |
KR (1) | KR102044585B1 (pt) |
CN (1) | CN104582721B (pt) |
BR (1) | BR112014031248A2 (pt) |
CA (1) | CA2876527C (pt) |
ES (2) | ES2438690B1 (pt) |
MX (1) | MX360904B (pt) |
MY (1) | MY169723A (pt) |
PH (1) | PH12014502796A1 (pt) |
PL (1) | PL2865388T3 (pt) |
RU (1) | RU2657753C2 (pt) |
UA (1) | UA116105C2 (pt) |
WO (1) | WO2013186409A1 (pt) |
ZA (1) | ZA201500270B (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107243008B (zh) * | 2017-04-13 | 2021-03-30 | 中国科学院广州生物医药与健康研究院 | 吡唑并[1,5-a]吡啶类化合物的新应用及一种治疗脓肿分枝杆菌感染的组合物 |
CN113907037B (zh) * | 2021-09-30 | 2023-04-28 | 重庆医科大学附属第一医院 | 一种气管支气管结核感染动物模型及其构建方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1038390C (zh) * | 1993-03-20 | 1998-05-20 | 张锦铭 | 灭活卡介苗组合物 |
WO2002102409A1 (en) * | 2001-06-19 | 2002-12-27 | Medical Research Council | Inactivated mycobacterial ompatb and uses thereof |
US20050175630A1 (en) * | 2003-12-23 | 2005-08-11 | Eyal Raz | Immunogenic compositions and methods of use thereof |
RU2006116429A (ru) * | 2006-05-12 | 2007-12-10 | Владислав Михайлович Коломиец (RU) | Способ лечения туберкулеза легких |
EP2144626B8 (en) * | 2007-04-12 | 2015-02-18 | Mico Bio, Inc. | Tuberculosis vaccine and method of using same |
WO2011008735A1 (en) * | 2009-07-13 | 2011-01-20 | Vaxgene Corporation | Oral vaccines produced and administered using edible micro-organism |
-
2012
- 2012-06-15 ES ES201200640A patent/ES2438690B1/es not_active Expired - Fee Related
-
2013
- 2013-06-13 UA UAA201500279A patent/UA116105C2/uk unknown
- 2013-06-13 EP EP13804005.0A patent/EP2865388B1/en active Active
- 2013-06-13 BR BR112014031248A patent/BR112014031248A2/pt not_active IP Right Cessation
- 2013-06-13 WO PCT/ES2013/000145 patent/WO2013186409A1/es active Application Filing
- 2013-06-13 US US14/407,179 patent/US9579371B2/en active Active
- 2013-06-13 ES ES13804005.0T patent/ES2694412T3/es active Active
- 2013-06-13 KR KR1020157000802A patent/KR102044585B1/ko active IP Right Grant
- 2013-06-13 MX MX2014015317A patent/MX360904B/es active IP Right Grant
- 2013-06-13 MY MYPI2014703791A patent/MY169723A/en unknown
- 2013-06-13 CN CN201380039138.6A patent/CN104582721B/zh not_active Expired - Fee Related
- 2013-06-13 JP JP2015516652A patent/JP6159396B2/ja not_active Expired - Fee Related
- 2013-06-13 CA CA2876527A patent/CA2876527C/en active Active
- 2013-06-13 PL PL13804005T patent/PL2865388T3/pl unknown
- 2013-06-13 RU RU2015101114A patent/RU2657753C2/ru active
-
2014
- 2014-12-15 PH PH12014502796A patent/PH12014502796A1/en unknown
-
2015
- 2015-01-14 ZA ZA2015/00270A patent/ZA201500270B/en unknown
Also Published As
Publication number | Publication date |
---|---|
PH12014502796B1 (en) | 2015-02-09 |
MX2014015317A (es) | 2015-05-11 |
KR102044585B1 (ko) | 2019-11-13 |
PH12014502796A1 (en) | 2015-02-09 |
ZA201500270B (en) | 2015-12-23 |
US20150174229A1 (en) | 2015-06-25 |
MX360904B (es) | 2018-11-21 |
MY169723A (en) | 2019-05-14 |
RU2015101114A (ru) | 2016-08-10 |
CN104582721A (zh) | 2015-04-29 |
ES2438690B1 (es) | 2015-01-16 |
EP2865388A1 (en) | 2015-04-29 |
CA2876527C (en) | 2020-04-21 |
PL2865388T3 (pl) | 2019-03-29 |
EP2865388B1 (en) | 2018-08-08 |
CA2876527A1 (en) | 2013-12-19 |
KR20150036051A (ko) | 2015-04-07 |
ES2438690A1 (es) | 2014-01-17 |
EP2865388A4 (en) | 2015-07-22 |
JP2015523351A (ja) | 2015-08-13 |
ES2694412T3 (es) | 2018-12-20 |
US9579371B2 (en) | 2017-02-28 |
JP6159396B2 (ja) | 2017-07-05 |
WO2013186409A8 (es) | 2015-01-29 |
UA116105C2 (uk) | 2018-02-12 |
WO2013186409A1 (es) | 2013-12-19 |
CN104582721B (zh) | 2018-01-26 |
RU2657753C2 (ru) | 2018-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015000420A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BR112014029115A2 (pt) | composto, composição farmacêutica, e, uso de um composto ou composição | |
BR302013002035S1 (pt) | Desenho ornamental para um absorvente higiênico. | |
CL2015000345A1 (es) | Uso de una combinación para el melanoma que comprende la administración de cobimetinib y vemurafenib. | |
BR112013020362A2 (pt) | processos para a preparação de compostos de quinolina, compostos e combinações farmacêuticas que os contem | |
BR112015002767A2 (pt) | composições, métodos, e sistemas para a síntese e uso de agentes de imagiologia | |
BR112014014769A2 (pt) | Composto, composição farmacêutica, e, uso de um composto ou sal. | |
CO7020897A2 (es) | Dispositivo de inhalación para fármacos en polvo | |
BR112015003259A2 (pt) | composto, composição farmacêutica, e, composição de vacina. | |
BR112015000534A2 (pt) | método para a preparação de 2,4-dihidroxibutirato, microrganismo, organismo e uso | |
BR112013030302A2 (pt) | composto, composição farmacêutica, uso de um composto, combinação de um composto e dispositivo | |
BR112015002824A2 (pt) | composto, uso de um composto, composição farmacêutica, e, produto farmacêutico de combinação. | |
ZA201503467B (en) | M. tuberculosis vaccines | |
BR112015031979A2 (pt) | letermovir, formulação farmacêutica oral sólida, uso de uma formulação farmacêutica oral sólida, e processo para preparar letermovir. | |
BR112014029642A2 (pt) | composto, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit | |
EP3352796A4 (en) | PARTICLE-BASED MEDICINAL FORMULATION COMPRISING A POLYSACCHARIDE-VITAMIN CONJUGATE | |
CL2014003283A1 (es) | Formulación farmacéutica. | |
BR112014016736A2 (pt) | composto, composição farmacêutica, método para tratamento, uso de um composto e invenção | |
CO7020911A2 (es) | Sistema para la administración de fármacos | |
UY34579A (es) | Dispositivo de inhalación para fármacos en polvo | |
DK3473255T3 (da) | Farmaceutisk formulering omfattende ciclesonid | |
BR112014020008A8 (pt) | composição farmacêutica, uso da mesma, e, processo para a fabricação de uma formulação. | |
EP3129052A4 (en) | Optimal dosing of a cd19-antibody drug conjugate | |
CR20140286A (es) | Dispositivo de inhalación para fármacos en polvo | |
BR112015005500A2 (pt) | composto, composição farmacêutica, combinação de um composto, uso de um composto e dispositivo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2779 DE 09-04-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |